Skip to main content

Traitement topique

  • Chapter
Hidradénite suppurée

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Lapins J, Jarstrand C, Emtestam L (1999) Coagulasenegative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol 140(1): 90–5

    Article  PubMed  CAS  Google Scholar 

  2. Clemmensen OJ (1983) Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol 22: 325–8

    Article  PubMed  CAS  Google Scholar 

  3. Jemec GB, Wendelboe P (1998) Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 39: 971–4

    Article  PubMed  CAS  Google Scholar 

  4. Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol 2003; 4: 473–92

    Article  PubMed  Google Scholar 

  5. Krautheim A, Gollnick H (2003) Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet 42: 1287–304

    Article  PubMed  CAS  Google Scholar 

  6. Parry MF, Rha CK (1986) Pseudomembranous colitis caused by topical clindamycin phosphate. Arch Dermatol 122: 583–4

    Article  PubMed  CAS  Google Scholar 

  7. Milstone EB, McDonald AJ, Scholhamer CF Jr. (1981) Pseudomembranous colitis after topical application of clindamycin. Arch Dermatol; 117: 154–5

    Article  PubMed  CAS  Google Scholar 

  8. Gollnick H, Cunliffe W, Berson D et al. (2003) Management of acne. Topical retinoids. J Am Acad Dermatol 49(Suppl 1): S5–S11

    Google Scholar 

  9. Yu CC, Cook MG (1990) Hidradenitis suppurativa: a disease of follicular epithelium rather than apocrine glands. Br J Dermatol 122: 763–9

    Article  PubMed  CAS  Google Scholar 

  10. Attanoos R, Appleton MAC, Douglas-Jones AG (1995) The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol 133: 254–8

    Article  PubMed  CAS  Google Scholar 

  11. Boer J, Weltevreden EF (1996) Hidradenitis suppurativa or acne inversa: a clinicopathological study of early lesions. Br J Dermatol 135: 721–5

    Article  PubMed  CAS  Google Scholar 

  12. Boer J, Dijkstra AT, Baar TJM (2201) Hidradenitis suppurativa (acne inversa): Lokale behandeling met resorcine. Ned Tijdschr Derm Venereol 11: 348–9

    Google Scholar 

  13. Boer J, Bos WH, Meer JB van der (2004) Hidradenitis suppurativa (acne inversa): behandeling met deroofing en resorcine (English abstract). Ned Tijdschr Derm Venereol 14: 274–8

    Google Scholar 

  14. Braun Falco O, Plewig G, Wolff HH et al. (1996) Diseases of the sebaceous Glands. In: Braun Falco O, Plewig G, Wolff HH, Burgdorf WHC (eds) Dermatology, 4th revised edn. Springer, Berlin Heidelberg New York pp 1051–82

    Google Scholar 

  15. Webster GF (2002) Acne vulgaris. Br Med J 325: 475–9

    Article  Google Scholar 

  16. Stienstra P (1975) Hidradenitis suppurativa. In: Jansen LH (ed) Huid en geslachtsziekten. Scheltema en Holkema, Utrecht pp 121–5

    Google Scholar 

  17. Polano MK (1984) Topical therapeutics. Churchill Livingstone, Edinburgh

    Google Scholar 

  18. Groot de AC (2000) Dermatological drugs, topical agents and cosmetics. In: Dukes MNG, Aronson JK (eds) Meyler’s side effects of drugs, 14th edn. Elsevier, Amsterdam p 473

    Google Scholar 

  19. Degreef H, Hulsebos HJ, Mariën KJC et al. (2000) Behandelingsprincipes. In: Vloten WA, van, Degreef HJ, Stolz E, Vermeer BJ, Willemze R (eds) Dermatologie en Venereologie, 3rd edn. Elsevier, Amsterdam

    Google Scholar 

  20. Mills OH, Kligman AM (1982) Assay of comedolytic activity in acne patients. Acta Dermatovenereol 63: 68–71

    Google Scholar 

  21. Mills OH, Kligman AM (1983) Drugs that are ineffective in the treatment of acne vulgaris. Br J Dermatol 108: 371–4

    Article  PubMed  Google Scholar 

  22. Wüthrich B, Zabrodsky S, Storck H (1970) Perkutane Vergiftungen durch Resorcin, Salicylsäure und weisse Präcipitatsalbe. Pharmaceutica Acta Helvetiae 45: 453–60

    PubMed  Google Scholar 

  23. Häckh G, Schwarzmüller E (1992) Codex dermatologischer Wirkstoffe. In: Niedner R, Ziegenmeyer J (eds) Dermatika. Wissenschaftliche Verlagsgesellschaft, Stuttgart pp 447–8

    Google Scholar 

  24. Werth von der JM, Williams HC (2000) The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 14: 389–92

    Article  PubMed  Google Scholar 

  25. Cunliffe WJ (2002) Looking back to the future-acne. Dermatology 204: 167–72

    Article  PubMed  CAS  Google Scholar 

  26. Cassano N, Alessandrini G, Mastrolonardo M et al. (1999) Peeling agents: toxicological and allergological aspects. J Eur Acad Dermatol Venereol 13: 14–23

    Article  PubMed  CAS  Google Scholar 

  27. Bontemps H, Mallaret M, Besson G et al. (1995) Confusion after topical use of resorcinol. Arch Dermatol 131: 112

    Article  PubMed  CAS  Google Scholar 

  28. Cunningham AA (1956) Resorcine poisoning. Arch Dis Child 31: 173–6

    Article  PubMed  CAS  Google Scholar 

  29. Plas M van der, Bos WH (1994) Chirurgische behandeling (epitheliale adnexcysten) door de dermatoloog (English abstract). Ned Tijdschr Derm Venereol 4: 101–3

    Google Scholar 

  30. Breathnach AS (1999) Azelaic acid: potential as a general antitumoural agent. Med Hypotheses 52: 221–6

    Article  PubMed  CAS  Google Scholar 

  31. Brasch J, Christophers E (1993) Azelaic acid has antimycotic properties in vitro. Dermatology 186: 55–8

    Article  PubMed  CAS  Google Scholar 

  32. Detmar M, Mayer-da-Silva A, Stadler R (1989) Effects of azelaic acid on proliferation and ultrastructure of mouse keratinocytes in vitro. J Invest Dermatol 93: 70–4

    Article  PubMed  CAS  Google Scholar 

  33. Topert M, Rach P, Siegmund F (1989) Pharmacology and toxicology of azelaic acid. Acta Dermatol Venereol Suppl (Stockh) 143: 14–9

    CAS  Google Scholar 

  34. Passi S, Picardo M, Mingrone G et al. (1989) Azelaic acid-biochemistry and metabolism. Acta Dermatol Venereol Suppl (Stockh) 143: 8–13

    CAS  Google Scholar 

  35. Galhaup I (1989) Azelaic acid: mode of action at cellular and subcellular levels. Acta Dermatol Venereol Suppl (Stockh) 143: 75–82

    CAS  Google Scholar 

  36. Bojar RA, Holland KT, Leeming JP, Cunliffe WJ (1988) Azelaic acid: its uptake and mode of action in Staphylococcus epidermidis NCTC 11047. J Appl Bacteriol 64: 497–504

    PubMed  CAS  Google Scholar 

  37. Wilkinson JD. Fusidic acid in dermatology. Br J Dermatol 1998;139[Suppl] 53: 37–40

    Article  PubMed  CAS  Google Scholar 

  38. Levine RM, Rasmussen JE (1983) Intralesional corticosteroids in the treatment of nodulocystic acne. Arch Dermatol 119: 480–1

    Article  PubMed  CAS  Google Scholar 

  39. Jansen T, Romiti R, Plewig G, Altmeyer P (2000) Disfiguring draining sinus tracts in a female acne patient. Pediatr Dermatol 17: 123–5

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag France, Paris,

About this chapter

Cite this chapter

Sartorius, K., Boer, J., Jemec, G.B.E. (2008). Traitement topique. In: Hidradénite suppurée. Springer, Paris. https://doi.org/10.1007/978-2-287-72063-5_21

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-72063-5_21

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-72062-8

  • Online ISBN: 978-2-287-72063-5

Publish with us

Policies and ethics